Pharmaceutical Analysis & Statistics, August 2014 (p40)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: therapeutics, drug, cancer, more »

1171-1220 of about 19 000 reports

Purchase Reports From Reputable Market Research Publishers

Drug Delivery Deals and Alliances of 2013

Drug Delivery Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Drug Delivery Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Drug Delivery Technology
Generic Pharma Deals and Alliances of 2013

Generic Pharma Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Generic Pharma Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Specialty Pharma Deals and Alliances of 2013

Specialty Pharma Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Specialty Pharma Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Big Biotech Deals and Alliances of 2013

Big Biotech Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the ...

  • Industries : Therapy
  • Countries : United States
Vaccine Deals and Alliances of 2013

Vaccine Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Vaccine Deals and Alliances of 2013 provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during ...

  • Industries : Drug and Medication
Marketed Stage Deals and Alliances of 2013

Marketed Stage Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Marketed Stage Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Clinical Stage Deals and Alliances of 2013

Clinical Stage Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Clinical Stage Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Pre-Clinical Stage Deals and Alliances of 2013

Pre-Clinical Stage Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Pre-Clinical Stage Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Discovery Stage Deals and Alliances of 2013

Discovery Stage Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Discovery Stage Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Sexual Health Deals and Alliances of 2013

Sexual Health Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Sexual Health Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Sensory Organ Deals and Alliances of 2013

Sensory Organ Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Sensory Organ Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Respiratory Deals and Alliances of 2013

Respiratory Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Respiratory Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Ophthalmics Deals and Alliances of 2013

Ophthalmics Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Ophthalmics Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Musculoskeletal Deals and Alliances of 2013

Musculoskeletal Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Musculoskeletal Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Metabolic Deals and Alliances of 2013

Metabolic Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Metabolic Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Infectives Deals and Alliances of 2013

Infectives Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Infectives Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Genitourinary Deals and Alliances of 2013

Genitourinary Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Genitourinary Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Gastrointestinal Deals and Alliances of 2013

Gastrointestinal Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Gastrointestinal Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Dental Deals and Alliances of 2013

Dental Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Dental Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Central Nervous System Deals and Alliances of 2013

Central Nervous System Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Central Nervous System Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Cardiovascular Deals and Alliances of 2013

Cardiovascular Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Cardiovascular Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Connected Care in Europe

Connected Care in Europe

  • $ 1 610
  • Industry report
  • October 2014
  • by Berg Insight AB

Executive summary The ageing population and the increasing prevalence of chronic diseases will be two of the greatest challenges in Europe during this century. It is widely believed that connected care ...

  • Industries : Pathology
  • Countries : Europe
Asia Pacific NIPT Market Outlook 2018

Asia Pacific NIPT Market Outlook 2018

  • $ 1 400
  • Industry report
  • September 2014
  • by RNCOS

Non-Invasive Prenatal Testing (NIPT) has catapulted growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, India, Japan, China, Asia, World, Oceania
Global Cancer Generics Market Outlook 2018

Global Cancer Generics Market Outlook 2018

  • $ 1 400
  • Industry report
  • August 2014
  • by RNCOS

With the advent of novel and innovative technologies, industries like healthcare and pharmaceutical are scaling newer heights. One such market is the oncology market. With global cancer incidences rising ...

  • Industries : Drug and Medication
  • Countries : World
Global miRNA Market Outlook to 2018

Global miRNA Market Outlook to 2018

  • $ 1 400
  • Industry report
  • August 2014
  • by RNCOS

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being ...

  • Industries : Pathology
  • Countries : World
Key Pharma News 06 OCTOBER 2014

Key Pharma News 06 OCTOBER 2014

  • $ 1 415
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Bayer's De-Diversification Presents Opportunities For Oncology Segment Industry Trend Analysis - Licence Agreement Helps Gilead Face Down Pressure Industry Trend Analysis - A ...

  • Industries : Drug and Medication
  • Countries : Japan
Key Pharma News 15 SEPTEMBER 2014

Key Pharma News 15 SEPTEMBER 2014

  • $ 1 415
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Merck Beats BMS To Market With Anti-PD-1 Therapy Industry Trend Analysis - Calico Collaboration To Further Expand AbbVie's Portfolio Industry Brief - Chugai Amends Business Arrangements ...

  • Industries : Pathology
  • Countries : Japan, United States
Aprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
Enzalutamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
Fosaprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
About 57 000 reports

Download Unlimited Documents from Trusted Public Sources

E-cigarette Market Forecast in the UK

  • Advertising of E-cigarettes
  • October 2014
    9 pages
  • E-cigarette  

    Smoking Treatme...  

  • United Kingdom  

    Europe  

View report >

Medication Market

October 2014

About 400 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.